title: Positive feedback loop between PI3K-Akt-mTORC1 signaling and the lipogenic pathway boosts Akt signaling: induction of the lipogenic pathway by a melanoma antigen.
abstract: The lipogenic phenotype is a metabolic hallmark of cancer cells. Sterol regulatory element-binding proteins (SREBP) are key transcriptional factors to regulate biosynthesis of cholesterol and fatty acids. It has been poorly understood how the lipogenic phenotype in cancer cells is regulated and how it augments their malignant properties. Here we describe roles of the melanoma antigen ganglioside GD3 and phosphatidylinositol 3-kinase (PI3K)-Akt-mTOR complex 1 (mTORC1) signaling in the regulation of SREBP activity, cholesterol biosynthesis, and the integrity of lipid rafts in human melanoma cells. GD3 expression induced the activation of both SREBP-1 and SREBP-2. Consequently, HMG-CoA reductase expression and cholesterol biosynthesis increased. The activation of the SREBP pathway was independent of the oncogenic BRAF mutation. On the other hand, it was regulated by PI3K-Akt-mTORC1 signaling in human melanoma cells. Disruption of the signaling pathway resulted in the reduction of cholesterol in lipid rafts. Inhibition of the SREBP pathway attenuated Akt activation in lipid rafts and suppressed the growth of human melanoma cells in vitro and in vivo. These results suggest that PI3K-Akt-mTORC1 signaling is important for the integrity of lipid rafts by regulating SREBP activation and subsequent cholesterogenesis. We thus propose a positive feedback circuit in which PI3K-Akt-mTORC1-SREBP signaling boosts Akt signaling in human melanoma cells expressing GD3.
authors.affiliation: Department of Biochemistry II, Nagoya University Graduate School of Medicine, Nagoya, Japan.
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Yamauchi
authors.forename: Keiko
authors.initials: K
authors.lastname: Furukawa
authors.forename: Kazunori
authors.initials: K
authors.lastname: Hamamura
authors.forename: Koichi
authors.initials: K
authors.lastname: Furukawa
mesh_terms: D000818:Animals; D025461:Feedback, Physiological; D005260:Female; D005732:Gangliosides / Q000096:biosynthesis; D006801:Humans; D050155:Lipogenesis; D000076222:Mechanistic Target of Rapamycin Complex 1; D008545:Melanoma / Q000276:immunology / Q000378:metabolism*; D021962:Membrane Microdomains / Q000378:metabolism*; D051379:Mice; D008807:Mice, Inbred BALB C; D046912:Multiprotein Complexes; D009154:Mutation; D051058:Oncogene Protein v-akt / Q000378:metabolism*; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism*; D011506:Proteins / Q000378:metabolism*; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics; D015398:Signal Transduction; D051779:Sterol Regulatory Element Binding Proteins / Q000378:metabolism; D058570:TOR Serine-Threonine Kinases; D014183:Transplantation, Heterologous
chemical_list: D005732:Gangliosides; D000076222:Mechanistic Target of Rapamycin Complex 1; D046912:Multiprotein Complexes; D051058:Oncogene Protein v-akt; D019869:Phosphatidylinositol 3-Kinases; D011506:Proteins; D048493:Proto-Oncogene Proteins B-raf; D051779:Sterol Regulatory Element Binding Proteins; D058570:TOR Serine-Threonine Kinases; C026226:ganglioside, GD3